A U.S. District Court in Delaware has decided in favor of United Therapeutics over Liquidia in one of its patent disputes over Tyvaso (treprostinil), a drug used to treat pulmonary arterial hypertension — abnormally high blood pressure in the arteries of the lungs.
Source: Drug Industry Daily